January 7, 2015 | Teva Pharmaceutical Industries received US Food & Drug Administration approval for the launch of a generic equivalent to Diovan, a drug used to treat high blood pressure by heart disease patients. Diovan is marketed by Novartis Pharmaceuticals and saw sales of up to $1.8 million in the US last year. In addition, Teva announced that it will be launching two generic versions of antibiotics in the US.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments